Showing 1 posts of 1 posts found.
The European Medicines Agency (EMA) has announced that it will conduct a review in an attempt to revise its guidelines …
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement
Panthera opens clinical trial site at Keele University